AbbVie (ABBV)
NYSEHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
$256.46-1.44%
Close 2026-09-04 · 1-day change
NYSEHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
QuarterlyIQ Insights · ABBV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenues | 64,386.0 | 61,160.0 | 56,334.0 | 54,318.0 | 58,054.0 | 56,197.0 | 45,804.0 | 33,266.0 | 25,638.0 | 25,638.0 | 25,638.0 | 22,859.0 | 18,380.0 | 18,380.0 |
| Total Revenues | 64,386.0 | 61,160.0 | 56,334.0 | 54,318.0 | 58,054.0 | 56,197.0 | 45,804.0 | 33,266.0 | 25,638.0 | 25,638.0 | 25,638.0 | 22,859.0 | 18,380.0 | 18,380.0 |
| Cost of Revenues | 18,365.0 | 18,204.0 | 16,904.0 | 20,415.0 | 17,414.0 | 17,446.0 | 15,387.0 | 7,439.0 | 5,832.0 | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | 6,698.0 | 6,283.0 | 5,459.0 | 5,241.0 | 4,925.0 | 4,333.0 | 3,829.0 |
| Operating Expenses & Income | ||||||||||||||
| Selling, General & Admin | 14,674.0 | 14,010.0 | 14,752.0 | 12,872.0 | 15,260.0 | 12,349.0 | 11,299.0 | 6,942.0 | 5,881.0 | 5,855.0 | 5,855.0 | 6,387.0 | 4,989.0 | 4,989.0 |
| Other Operating Expenses, Total | — | 241.0 | 7.0 | 179.0 | (56.0) | (432.0) | 0.0 | 890.0 | — | — | — | — | — | — |
| Operating Income | 16,870.0 | 15,075.0 | 9,137.0 | 12,757.0 | 18,117.0 | 17,924.0 | 11,363.0 | 12,983.0 | 9,340.0 | 9,384.0 | 9,384.0 | 7,537.0 | 5,817.0 | 5,817.0 |
| Earnings from Continuing Operations | ||||||||||||||
| Interest Expense | 2,916.0 | 2,893.0 | 2,808.0 | 2,224.0 | 2,230.0 | 2,423.0 | 2,454.0 | 1,784.0 | 1,047.0 | 1,047.0 | 1,047.0 | 719.0 | 104.0 | 104.0 |
| EBT, Incl. Unusual Items | 8,699.0 | 6,597.0 | 3,716.0 | 6,250.0 | 13,477.0 | 12,989.0 | 3,398.0 | 8,426.0 | 7,884.0 | 7,884.0 | 7,884.0 | 6,645.0 | 5,725.0 | 5,725.0 |
| Income Tax Expense | 2,383.0 | 2,364.0 | (570.0) | 1,377.0 | 1,632.0 | 1,440.0 | (1,224.0) | 544.0 | 1,931.0 | 1,931.0 | 1,931.0 | 1,501.0 | 450.0 | 450.0 |
| Net Income | ||||||||||||||
| Minority Interest | 6.0 | 7.0 | 8.0 | 10.0 | 9.0 | 7.0 | 6.0 | — | — | — | — | — | — | — |
| Net Income | 6,310.0 | 4,226.0 | 4,278.0 | 4,863.0 | 11,836.0 | 11,542.0 | 4,616.0 | 7,882.0 | 5,953.0 | 5,953.0 | 5,953.0 | — | — | — |
| Per Share | ||||||||||||||
| Basic EPS | 3.57 | 2.37 | 2.40 | 2.73 | 6.65 | 6.48 | 2.73 | 5.30 | 3.65 | 3.65 | 3.65 | 3.15 | 3.35 | 3.35 |
| Diluted EPS | 3.56 | 2.36 | 2.39 | 2.72 | 6.63 | 6.45 | 2.72 | 5.28 | 3.63 | 3.63 | 3.63 | 3.13 | 3.35 | 3.35 |
| Revenue per Share | 36.36 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | 6.83 | 6.65 | 6.29 | 5.99 | 5.71 | 5.31 | 4.84 | 4.39 | 1.07 | 2.35 | 2.35 | 2.10 | 1.75 | 2.00 |
| Basic Weighted Avg Shares | 1,769.0 | 1,769.0 | 1,769.0 | 1,768.0 | 1,771.0 | 1,770.0 | 1,667.0 | 1,481.0 | 1,622.0 | 1,622.0 | 1,622.0 | 1,625.0 | 1,577.0 | 1,577.0 |
| Diluted Weighted Avg Shares | 1,771.0 | 1,773.0 | 1,773.0 | 1,773.0 | 1,778.0 | 1,777.0 | 1,673.0 | 1,484.0 | 1,631.0 | 1,631.0 | 1,631.0 | 1,637.0 | 1,577.0 | 1,577.0 |
| Payout Ratio | 191.7% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||
| EBIT | 16,870.0 | 15,075.0 | 9,137.0 | 12,757.0 | 18,117.0 | 17,924.0 | 11,363.0 | 12,983.0 | 9,340.0 | 9,384.0 | 9,384.0 | 7,537.0 | 5,817.0 | 5,817.0 |
| Effective Tax Rate | 27.4% | — | — | 22.0% | 12.1% | 11.1% | -36.0% | 6.5% | 24.5% | 24.5% | 24.5% | 22.6% | 7.9% | 7.9% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.